Enriched environment protects the nigrostriatal dopaminergic system and induces astroglial reaction in the 6-OHDA rat model of Parkinson's disease

Journal of Neurochemistry

Volumn 109, Issue 3, 2009, Pages 755-765

  Anastasía, Agustín ^a   Torre, Luciana ^a   De Erausquin, Gabriel A ^b   Mascó, Daniel H ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

6 hydroxydopamine; Astrocytes; Enriched environment; Neuroprotection

Indexed keywords

OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL SURVIVAL; COGNITION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; LIFESTYLE; MALE; MOTOR DYSFUNCTION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; SOCIAL INTERACTION; SUBSTANTIA NIGRA;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; ENVIRONMENT; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, WISTAR; ROTAROD PERFORMANCE TEST; STILBAMIDINES; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; RATTUS;

EID: 64149107612     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06001.x     Document Type: Article

References (61)

1. Anastasía A., De Erausquin G. A., Wojnacki J. Mascó D. H. (2007) Protection of dopaminergic neurons by electroconvulsive shock in an animal model of Parkinson's disease. J. Neurochem. 103, 1542 1552.
2. Aponso P., Faull R. Connor B. (2008) Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease. Neuroscience 151, 1142 1153.
3. Bezard E., Dovero S., Belin D., Duconger S., Jackson-Lewis V., Przedborski S., Piazza P. V., Gross C. E. Jaber M. (2003) Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors. J. Neurosci. 23, 10999 11007.
4. Bowenkamp K., David D., Lapehak P., Henry M., Granholm A., Hoffer B. J. Mahalik T. (1996) 6-Hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. Exp. Brain Res. 111, 7 9.
5. Carman L. S., Gage F. H. Shults C. W. (1991) Partial lesion of the substantia nigra: relation between extent of lesion and rotational behaviour. Brain Res. 553, 275 283.
6. Chadi G. Gomide V. (2004) FGF-2 and S100β immunoreactivities increase in reactive astrocytes, but not in microglia, in ascending dopamine pathways following a striatal 6-OHDA induced partial lesion of the nigrostriatal system. Cell Biol. Int. 28, 849 861.
7. Chen H., Zhang S., Schwarzschild M., Hernán M. Ascherio A. (2005) Physical activity and the risk of Parkinson disease. Neurology 64, 664 669.
8. Damier P., Hirsch E., Agid Y. Graybiel A. M. (1999) The Substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122, 1437 1448.
9. Dauer W. Przedborski S. (2003) Parkinson's disease: mechanisms and models. Neuron 39, 889 909.
10. van Dellen A., Blakemore C., Deacon R., York D. Hannan A. J. (2000) Delaying the onset of Huntington's in mice. Nature 404, 721 722.
11. Depino A. M., Earl C., Kaczmarczyk E., Ferrari C., Besedovsky H., del Rey A., Pitossi F. J. Oertel W. H. (2003) Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease. Eur. J. Neurosci. 18, 2731 2742.
12. Dowd E. s., Monville C., Torres E. M., Wong L.-F., Azzouz M., Mazarakis N. D. Dunnett S. B. (2005) Lentivector-mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model. Eur. J. Neurosci. 22, 2587 2595.
13. Elbaz A. Moisan F. (2008) Update in the epidemiology of Parkinson's disease. Curr. Opin. Neurol. 21, 454 460.
14. Escartin C. Bonvento G. (2008) Targeted activation of astrocytes: a potential neuroprotective strategy. Mol. Neurobiol. 38, 231 241.
15. Faherty C. J., Raviie Shepherd K., Herasimtschuk A. Smeyne R. J. (2005) Enviromental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism. Mol. Brain Res. 134, 170 179.
16. Freundlieb N., François C., Tandé D., Oertel W. H., Hirsch E. C. Höglinger G. U. (2006) Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates. J. Neurosci. 26, 2321 2325.
17. Frigerio R., Elbaz A., Sanft K., Peterson B., Bower J., Ahlskog J., Grossardt B., De Andrade M., Maraganore D. Rocca W. (2005) Education and occupations preceding Parkinson disease: a population-based case-control study. Neurology 65, 1575 1583.
18. Gibb W. Lees A. (1991) Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiatr. 54, 388 396.
19. Gobbo O. O′Mara S. (2004) Impact of enriched environment housing on brain-derived neurotrophic factor and on cognitive performance after a transient global ischemia. Behav. Brain Res. 152, 231 241.
20. Gomide V., Bibancos T. Chadi G. (2005a) Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific stereological tools. Int. J. Neurosci. 115, 582.
21. Gomide V., Silveira G. Chadi G. (2005b) Transient and widespread astroglial activation in the brain after a striatal 6-OHDA-induced partial lesion of the nigrostriatal system. Int. J. Neurosci. 115, 99 117.
22. Gordon M. N., Schreier W. A., Ou X., Holcomb L. A. Morgan D. G. (1997) Exaggerated astrocyte reactivity after nigrostriatal deafferentiation in the aged rat. J. Comp. Neurol. 388, 106 119.
23. Hagg T. Varon S. (1993) Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc. Natl Acad. Sci. USA 90, 3619.
24. Henning J., Strauss U., Wree A., Gimsa J., Rolfs A., Benecke R. Gimsa U. (2008) Differential astroglial activation in 6-hydroxydopamine models of Parkinson's disease. Neurosci. Res. 62, 246 253.
25. Hyman C., Hofer M., Barde Y.-A., Juhasz M., Yancopoulos G. D., Squinto S. P. Lindsay R. M. (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230 232.
26. Ickes B. R., Pham T. M., Sanders L. A., Albeck D. S., Mohammed A. H. Granholm A.-C. (2000) Long-term environmental enrichment leads to regional increases in neurotrophin levels in rat brain. Exp. Neurol. 164, 45 52.
27. Jadavji N., Kolb B. Metz G. (2006) Enriched environment improves motor function in intact and unilateral dopamine-depleted rats. Neuroscience 140, 1127 1138.
28. Kearns C. M., Cass W. A., Smoot K., Kryscio R. Gash D. M. (1997) GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis. J. Neurosci. 17, 7111 7118.
29. Kipp M., Karakaya S., Pawlak J., Araujo-Wright G., Arnold S. Beyer C. (2006) Estrogen and the development and protection of nigrostriatal dopaminergic neurons: concerted action of a multitude of signals, protective molecules, and growth factors. Front. Neuroendocrin. 27, 376 390.
30. Kirik D., Rosenblad C. Björklund A. (2000) Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor. Eur. J. Neurosci. 12, 3871 3882.
31. Laviola G., Hannan A. J., Macrí S., Solinas M. Jaber M. (2008) Effects of enriched environment on animal models of neurodegenerative diseases and psychiatric disorders. Neurobiol. Dis. 31, 159 168.
32. Liberto C. M., Albrecht P., Herx L., Yong V. Levison S. (2004) Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 89, 1092 1100.
33. Lie D. C., Dziewczapolski G., Willhoite A. R., Kaspar B. K., Shults C. W. Gage F. H. (2002) The adult substantia nigra contains progenitor cells with neurogenic potential. J. Neurosci. 22, 6639 6649.
34. Mabandla M., Kellaway L., St Clair Gibson A. Russell V. A. (2004) Voluntary running provides neuroprotection in rats after 6-hydroxydopamine injection into the medial forebrain bundle. Metab. Brain Dis. 19, 43 50.
35. McGeer P. L. McGeer E. G. (2008) Glial reactions in Parkinson's disease. Mov. Disord. 23, 474 483.
36. McOmish C. Hannan A. (2007) Enviromimetics: exploring gene environment interacitons to identify therapeutic targets for brain disorders. Expert Opin. Ther. Targets 11, 899 913.
37. National Academy Press (1996) Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, D.C.
38. Nithianantharajah J. Hannan A. (2006) Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat. Rev. Neurosci. 7, 697 709.
39. Olanow C. Tatton W. (1999) Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22, 123 144.
40. Paul G., Meissner W., Rein S., Harnack D., Winter C., Hosmann K., Morgenstern R. Kupsch A. (2004) Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease. Exp. Neurol. 185, 272 280.
41. Paxinos G. Watson C. (2007) The Rat Brain in Stereotaxic Coordinates, Sixth Edition. Academic Press, London.
42. Peterson A. L. Nutt J. G. (2008) Treatment of Parkinson's disease with trophic factors. Neurotherapeutics 5, 270 280.
43. Petzinger G. M., Walsh J. P., Akopian G. et al. (2007) Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine lesioned mouse model of basal ganglia injury. J. Neurosci. 27, 5291 5300.
44. Pham T., Ickes B., Albeck D., Soderstrom S., Granholm A. Mohammed A. (1999) Changes in brain nerve growth factor levels and nerve growth factor receptors in rats exposed to environmental enrichment for one year. Neuroscience 94, 279 286.
45. van Praag H., Kempermann G. Gage F. H. (2000) Neural consequences of environmental enrichment. Nat. Rev. Neurosci. 1, 191 198.
46. Sauer H. Oertel W. H. (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions witr 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59, 401 415.
47. Schallert T., Leasure J. L. Kolb B. (2000) Experience-associated structural events, subependymal cellular proliferative activity, and functional recovery after injury to the central nervous system. J. Cereb. Blood Flow Metab. 20, 1513 1528.
48. Schmued L. C. Hopkins K. J. (2000) Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 4, 123 130.
49. Schwartz J. P. Nishiyama N. (1994) Neurotrophic factor gene expression in astrocytes during development and following injury. Brain Res. Bull. 35, 403 407.
50. Shults C. W., Ray Jasodhara R., Tsuboi K. Gage F. H. (2000) Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine. Brain Res. 883, 192 204.
51. Spires T. L., Grote H. E., Varshney N. K., Cordery P. M., van Dellen A., Blakemore C. Hannan A. J. (2004) Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism. J. Neurosci. 24, 2270 2276.
52. Stam N. C., Nithianantharajah J., Howard M. L., Atkin J. D., Cheema S. S. Hannan A. J. (2008) Sex-specific behavioural effects of environmental enrichment in a transgenic mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 28, 717 723.
53. Steiner B., Winter C., Hosman K., Siebert E., Kempermann G., Petrus D. S. Kupsch A. (2006) Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease. Exp. Neurol. 201, 1 6.
54. Teissmann P., Tieu K., Cohen O., Choi D.-K., Wu D. C., Marks D., Vila M., Jackson-Lewis V. Przedborski S. (2003) Pathogenic role of glial cells in Parkinson's disease. Mov. Disord. 18, 121 129.
55. Thacker E. L., Chen H., Patel A. V., McCullough M. L., Calle E. E., Thun M. J., Schwarzschild M. A. Ascherio A. (2008) Recreational physical activity and risk of Parkinson's disease. Mov. Disord. 23, 69 74.
56. Tillerson J., Caudle W., Reverón M. Miller G. (2003) Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease. Neuroscience 119, 899 911.
57. Turner C. A. Lewis M. H. (2003) Environmental enrichment: effects on stereotyped behavior and neurotrophin levels. Physiol. Behav. 80, 259 266.
58. Ungerstedt U. (1968) 6-Hydroxydopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5, 107 110.
59. Visanji N. P., Orsi A., Johnston T. H., Howson P. A., Dixon K., Callizot N., Brotchie J. Rees D. D. (2008) PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease. FASEB J. 22, 2488 2497.
60. Yoon M.-C., Shin M.-S., Kim T.-S., Kim B.-K., Ko I.-G., Sung Y.-H., Kim S.-E., Lee H.-H., Kim Y.-P. Kim C.-J. (2007) Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats. Neuroscie. Lett. 423, 12 17.
61. Zuch C. L., Nordstroem V. K., Briedrick L. A., Hoernig G., Granholm A.-C. Bickford P. C. (2000) Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion. J. Comp. Neurol. 427, 440 454.